SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Álvarez-Mon MA, Pereira V, Ortuño F. Medicine (Spain) 2017; 12(46): 2731-2742.

Copyright

(Copyright © 2017)

DOI

10.1016/j.med.2017.12.001

PMID

unavailable

Abstract

Introduction Major depressive disorder is the main depressive disorder included in DSM-5. It affects people of all ages and both sexes, and manifests with cognitive, behavioural and affective changes. The risk of suicide is high. Drug treatment There are several effective drugs for depressive disorders that are classified according to their mechanism of action. The selective serotonin reuptake inhibitors (SSRI) are at the forefront in terms of efficacy and safety. Non-drug treatment Of the neuromodulation techniques, electroconvulsive therapy (ECT) is an effective alternative for cases that are refractory to drug treatment. Moreover, lifestyle changes and some psychotherapeutic interventions can be useful for many patients. Treatment protocol SSRI are the first-line treatment for major treatment, and other drugs can be used as substitutes or adjuvants in subsequent treatment lines. ECT should be considered for treatment-refractory depression in adults and pregnant women. © 2017


Language: en

Keywords

Electroconvulsive therapy; Major depressive disorder; Psychotherapy; Selective serotonin reuptake inhibitors

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print